相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Reversing HOXA9 Oncogene Activation by PI3K Inhibition: Epigenetic Mechanism and Prognostic Significance in Human Glioblastoma
Bruno M. Costa et al.
CANCER RESEARCH (2010)
EGFRvIII and DNA Double-Strand Break Repair: A Molecular Mechanism for Radioresistance in Glioblastoma
Bipasha Mukherjee et al.
CANCER RESEARCH (2009)
NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas
Ta-Jen Liu et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility
Margaret Wrensch et al.
NATURE GENETICS (2009)
EGFR Signals to mTOR Through PKC and Independently of Akt in Glioma
Qi-Wen Fan et al.
SCIENCE SIGNALING (2009)
Phosphatidylinostol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis
Daniela Opel et al.
CANCER RESEARCH (2008)
Histone deacetylase inhibition and blockade of the glycolytic pathway synergistically induce glioblastoma cell death
Vivian Egler et al.
CLINICAL CANCER RESEARCH (2008)
Correlation of O6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E. Hegi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status
Catia Cemeus et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Apoptosis: controlled demolition at the cellular level
Rebecca C. Taylor et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Constitutive activation of Raf-1 induces glioma formation in mice
Yelena Lyustikman et al.
NEOPLASIA (2008)
A dual phosphoinositide-3-kinase α/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma
Qi-Wen Fan et al.
CANCER RESEARCH (2007)
Loss of NOTCH2 Positively Predicts Survival in Subgroups of Human Glial Brain Tumors
Jean-Louis Boulay et al.
PLOS ONE (2007)
Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment
F. Meier et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles
Dagmar Beier et al.
CANCER RESEARCH (2007)
EGFR inhibition in glioblastoma cells induces G2/M arrest and is independent of p53
Gurpreet S. Kapoor et al.
CANCER BIOLOGY & THERAPY (2007)
Rare cancer-specific mutations in PIK3CA show gain of function
Marco Gymnopoulos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Combination of sublethal concentrations of epidermal growth factor receptor inhibitor and microtubule stabilizer induces apoptosis of glioblastoma cells
Mike Failly et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: Possible role for thrombosis
Sherry A. Weppler et al.
RADIOTHERAPY AND ONCOLOGY (2007)
A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis
Sofia Baka et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2006)
New approaches to molecular cancer therapeutics
Ian Collins et al.
NATURE CHEMICAL BIOLOGY (2006)
Human cancers express a mutator phenotype
Jason H. Bielas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Isoform specific inhibitors of PI3 kinase in glioma
Qi-Wen Fan et al.
CELL CYCLE (2006)
PIK3CA gene mutations in pediatric and adult glioblastoma multiforme
Gary L. Gallia et al.
MOLECULAR CANCER RESEARCH (2006)
Clinical implications of the mechanism of epidermal growth factor receptor inhibitors
John Marshall
CANCER (2006)
High-grade glioma formation results from postnatal Pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model
Qingxia Wei et al.
CANCER RESEARCH (2006)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
Local targeting of malignant gliomas by the diffusible peptidic vector 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid-substance P
Stefan Kneifel et al.
CLINICAL CANCER RESEARCH (2006)
Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation
LC Foukas et al.
NATURE (2006)
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
Qi-Wen Fan et al.
CANCER CELL (2006)
Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma
D Koul et al.
MOLECULAR CANCER THERAPEUTICS (2006)
PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry
M Groszer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Use of APO2L/TRAIL with mTOR inhibitors in the treatment of glioblastoma multiforme
Amith Panner et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastorna multiforme
DA Reardon et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The PI3K inhibitor LY294002 prevents p53 induction by DNA damage and attenuates chemotherapy-induced apoptosis
J Bar et al.
CELL DEATH AND DIFFERENTIATION (2005)
Glucose transporter 4: cycling, compartments and controversies - Third in the cycles review series
CB Dugani et al.
EMBO REPORTS (2005)
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
IK Mellinghoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The natural history of EGFR and EGFRvIII in glioblastoma patients
AB Heimberger et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 30H-kinase
T Nobukuni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
N Thatcher et al.
LANCET (2005)
Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells
RD Rao et al.
NEOPLASIA (2005)
Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas
CB Knobbe et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2005)
hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase
MP Byfield et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: A north central cancer treatment group study
E Galanis et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma
TE Witzig et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
SM Chang et al.
INVESTIGATIONAL NEW DRUGS (2005)
Regulation of cancer cell motility through actin reorganization
D Yamazaki et al.
CANCER SCIENCE (2005)
Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation
A Xiao et al.
CANCER RESEARCH (2005)
Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas
H Ohgaki et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
PIK3CA mutations in glioblastoma multiforme
C Hartmann et al.
ACTA NEUROPATHOLOGICA (2005)
Actin polymerization machinery: the finish line of signaling networks, the starting point of cellular movement
A Disanza et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Phosphoinositide 3-kinase in disease: timing, location, and scaffolding
MP Wymann et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis
F Lefranc et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas
JW Lee et al.
ONCOGENE (2005)
Combination-treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774
T Efferth et al.
BIOCHEMICAL PHARMACOLOGY (2004)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas
CB Knobbe et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas
DK Broderick et al.
CANCER RESEARCH (2004)
Chemotaxis: Signalling the way forward
PJM Van Haastert et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy
JJ Raizer et al.
NEURO-ONCOLOGY (2004)
Mutation of the PIK3CA gene in ovarian and breast cancer
IG Campbell et al.
CANCER RESEARCH (2004)
Phase II trial of gefitinib in recurrent glioblastoma
JN Rich et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
PTEN methylation and expression in glioblastomas
N Baeza et al.
ACTA NEUROPATHOLOGICA (2003)
Inhibition of phosphatidylinositol 3-kinase signaling negates the growth advantage imparted by a mutant epidermal growth factor receptor on human glioblastoma cells
M Klingler-Hoffmann et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty
BMT Burgering et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Growth inhibition of human malignant glioma cells induced by the PI3-K-specific inhibitor
T Shingu et al.
JOURNAL OF NEUROSURGERY (2003)
Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope
M Castedo et al.
EMBO JOURNAL (2002)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
The role of phosphatidylinositol 3-kinase, Rho family GTPases, and STAT3 in Ros-induced cell transformation
KT Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
M Guba et al.
NATURE MEDICINE (2002)
Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-κB
C Murga et al.
ONCOGENE (2002)
Increased insulin sensitivity in mice lacking p85β subunit of phosphoinositide 3-kinase
K Ueki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme
MD Groves et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo
M Groszer et al.
SCIENCE (2001)
Mechanisms of resistance to rapamycins
S Huang et al.
DRUG RESISTANCE UPDATES (2001)
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme
JS Smith et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Akt-dependent phosphorylation of p21Cip1 regulates PCNA binding and proliferation of endothelial cells
L Rössig et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis
H Sasaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Malignant glioma: genetics and biology of a grave matter
EA Maher et al.
GENES & DEVELOPMENT (2001)
The class II phosphoinositide 3-kinase C2α is activated by clathrin and regulates clathrin-mediated membrane trafficking
I Gaidarov et al.
MOLECULAR CELL (2001)
Rapamycin reduces hybridoma cell death and enhances monoclonal antibody production
RR Balcarcel et al.
BIOTECHNOLOGY AND BIOENGINEERING (2001)
Wortmannin sensitizes human glioblastoma cell lines carrying mutant and wild type TP53 gene to radiation
N Kubota et al.
CANCER LETTERS (2000)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Cell signaling by receptor tyrosine kinases
J Schlessinger
CELL (2000)
TOR, a central controller of cell growth
T Schmelzle et al.
CELL (2000)
Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases
J Liliental et al.
CURRENT BIOLOGY (2000)
Phosphoinositide signaling and the regulation of membrane trafficking in yeast
G Odorizzi et al.
TRENDS IN BIOCHEMICAL SCIENCES (2000)
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice
EC Holland et al.
NATURE GENETICS (2000)
分享论文
